Evaluation of the Predictive Value of the Optic Nerve Involvement at the Stage of Clinically Isolated Syndrome, for the Diagnosis of Clinically Definite Multiple Sclerosis and the Delay of Second Relapses' Occurrence

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Optic neuritis (ON) represents around 30% of clinical presentation of clinically isolated syndrome (CIS). Asymptomatic optic nerve involvement is very frequent in all stage of multiple sclerosis (MS) disease including the CIS. However, optic nerve is still not part of MS diagnosis criteria. The main objective of our regional and multicenter study is to evaluate the prognostic value of optic nerve involvement at the earliest clinical stage of MS (=CIS) for the diagnosis of clinically definite MS (2nd clinical relapse) and the delay until the 2nd relapse.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 55
Healthy Volunteers: f
View:

• Patients between 18 and 55 years old

• Occurrence of CIS ≤ 6 months

• With two T2 hypersignals on brain/spinal cord MRI suggestive of MS or with oligoclonal bands

• Giving their written informed consent

Locations
Other Locations
France
Hôpital Roger Salengro
RECRUITING
Lille
Contact Information
Primary
Juliette Bochu
juliette.bochu@chu-lille.fr
0320444145
Time Frame
Start Date: 2025-07-17
Estimated Completion Date: 2028-07-01
Participants
Target number of participants: 200
Treatments
Experimental: All patients will part of the same follow-up study.
All patients will part of the same follow-up study. No treatment will be compared. Patients will be treated as recommended.
Related Therapeutic Areas
Sponsors
Collaborators: Amiens University Hospital, Centre Hospitalier de Roubaix, Centre Hospitalier de Lens, Boulogne sur Mer Hospital Center, Région Nord-Pas de Calais, France, Centre Hospitalier VALENCIENNES
Leads: University Hospital, Lille

This content was sourced from clinicaltrials.gov